A Case Report of Adalimumab Successfully Treated a Severe Plaque Psoriasis Patient with Psoriatic End-Stage Renal Disease

Jing Xu1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information

Aijun Chen1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information

Yuting Peng1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information

Zhuyuan Wen1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China;2 College of Pediatric, Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information

Kun Huang1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information

Ping Wang1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Pages 2841-2846 | Received 11 May 2023, Accepted 20 Aug 2023, Published online: 12 Oct 2023

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Armstrong AW, Read C. Pathophysiology, Clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960.
PubMed Web of Science ®Google Scholar
Amin M, Lee EB, Tsai TF, Wu JJ. Psoriasis and co-morbidity. Acta Derm Venereol. 2020;100(3):adv00033. doi:10.2340/00015555-3387
PubMed Web of Science ®Google Scholar
Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol. 2022;13:2484.
Web of Science ®Google Scholar
Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377–390.
PubMed Web of Science ®Google Scholar
Grewal SK, Wan J, Denburg MR, Shin DB, Takeshita J, Gelfand JM. The risk of IgA nephropathy and glomerular disease in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2017;176(5):1366–1369. doi:10.1111/bjd.14961
PubMed Web of Science ®Google Scholar
Tokuyama M, Shimizu T, Yamada T, Kondoh A, Mabuchi T. Case of psoriasis vulgaris with atrial fibrillation, heart failure and chronic kidney disease which were found accidentally through blood examination during apremilast treatment. J Dermatol. 2019;46(7):e239–e240. doi:10.1111/1346-8138.14784
PubMed Web of Science ®Google Scholar
Sakemi T, Hayashida R, Ikeda Y, Baba N, Nishihara G, Kohda H. Membranous glomerulonephropathy associated with psoriasis vulgaris. Nephron. 1996;72(2):351–352.
PubMed Web of Science ®Google Scholar
Honma M, Hayashi K. Psoriasis: recent progress in molecular-targeted therapies. J Dermatol. 2021;48(6):761–777.
PubMed Web of Science ®Google Scholar
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315.
PubMed Web of Science ®Google Scholar
Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: implications for management. J Am Acad Dermatol. 2017;76(3):393–403. doi:10.1016/j.jaad.2016.07.065
PubMed Web of Science ®Google Scholar
Visconti L, Leonardi G, Buemi M, et al. Kidney disease and psoriasis: novel evidences beyond old concepts. Clin Rheumatol. 2016;35(2):297–302. doi:10.1007/s10067-015-3126-4
PubMed Web of Science ®Google Scholar
Conti A, Giovannini L, Mandel VD, et al. Chronic kidney disease in psoriasis: a cohort study. J Dtsch Dermatol Ges. 2020;18(5):438–445.
Web of Science ®Google Scholar
Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347(oct15 7):f5961. doi:10.1136/bmj.f5961
PubMedGoogle Scholar
Schonmann Y, Mansfield KE, Mulick A, et al. Inflammatory skin diseases and the risk of chronic kidney disease: population-based case-control and cohort analyses. Br J Dermatol. 2021;185(4):772–780. doi:10.1111/bjd.20067
PubMed Web of Science ®Google Scholar
Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232–238. doi:10.1016/j.jdermsci.2015.03.012
PubMed Web of Science ®Google Scholar
Chiu HY, Huang HL, Li CH, et al. Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol. 2015;173(1):146–154. doi:10.1111/bjd.13599
PubMed Web of Science ®Google Scholar
Kusakari Y, Yamasaki K, Takahashi T, et al. Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: a case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure. J Dermatol. 2015;42(7):727–730. doi:10.1111/1346-8138.12901
PubMed Web of Science ®Google Scholar
Skutnik-Radziszewska A, Maciejczyk M, Flisiak I, et al. Enhanced inflammation and nitrosative stress in the saliva and plasma of patients with plaque psoriasis. J Clin Med. 2020;9(3). doi:10.3390/jcm9030745
PubMed Web of Science ®Google Scholar
Li H, Tsokos MG, Bhargava R, et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J Clin Invest. 2021;131(12). doi:10.1172/JCI142428
Web of Science ®Google Scholar
Mehaffey E, Majid DSA. Tumor necrosis factor-alpha, kidney function, and hypertension. Am J Physiol Renal Physiol. 2017;313(4):F1005–F1008. doi:10.1152/ajprenal.00535.2016
PubMed Web of Science ®Google Scholar
Lavoz C, Matus YS, Orejudo M, et al. Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. Kidney Int. 2019;95(6):1418–1432. doi:10.1016/j.kint.2018.12.031
PubMed Web of Science ®Google Scholar
Veronesi G, Guglielmo A, Gardini A, et al. Biological therapy in patients with psoriasis: what we know about the effects on renal function. Dermatol Ther. 2022;35(1):e15202. doi:10.1111/dth.15202
PubMed Web of Science ®Google Scholar
Maghfour J, Elliott E, Gill F, Stumpf B, Murina A. Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease. J Am Acad Dermatol. 2020;82(5):1249–1251. doi:10.1016/j.jaad.2019.12.043
PubMed Web of Science ®Google Scholar
Posner J, Barrington P, Brier T, Datta-Mannan A. Monoclonal antibodies: past, present and future. Handb Exp Pharmacol. 2019;260:81–141.
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A Case Report of Adalimumab Successfully Treated a Severe Plaque Psoriasis Patient with Psoriatic End-Stage Renal Disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A Case Report of Adalimumab Successfully Treated a Severe Plaque Psoriasis Patient with Psoriatic End-Stage Renal Disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date